NZD/USD Price Forecast: Plunges below 0.6100 on RBNZ 50 bps rate cut

Source Fxstreet
  • NZD/USD plummets below 0.6100 as the RBNZ reduced its OCR further by 50 bps to 4.75%.
  • The RBNZ was expected to deliver a hefty rate cut amid weak growth prospects.
  • Investors await the FOMC minutes for fresh cues on the interest rate outlook.

The NZD/USD pair faces an intense sell-off and slides below the round-level support of 0.6100 in Wednesday’s North American session. The Kiwi pair plunges as the Reserve Bank of New Zealand (RBNZ) has cut its Official Cash Rate (OCR) by 50 basis points (bps) to 4.75%.

The RBNZ was expected to deliver a larger-than-usual interest rate cut due to softening labor market conditions and subdued growth. Market participants expect the RBNZ to reduce interest rates at a similar pace again in November.

Meanwhile, dismal market sentiment due to Middle East risks has also dampened the appeal of risk-sensitive assets. The US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, climbs to near 102.70.

The US Dollar strengthens as traders have priced out the scenario of the Federal Reserve (Fed) to reduce interest rates again by 50 bps in November. The Fed started the policy-easing cycle with a sizeable cut of 50 bps in September. Meanwhile, investors await Federal Open Market Committee (FOMC) Minutes for the September meeting, which will be published at 18:00 GMT.

NZD/USD weakens after breaking below the horizontal support plotted from the September 11 low of 0.6100 on a daily timeframe. The overall trend of the Kiwi pair has become bearish as it has formed a lower swing low. The asset is also trading below the 50-day Exponential Moving Average (EMA), which trades around 0.6173.

The 14-day Relative Strength Index (RSI) slides below 40.00, suggesting that a bearish momentum has been triggered.

More downside is highly likely towards the psychological support of 0.6000 and the August 15 low of 0.5974.

On the flip side, a reversal move above the October 8 high of 0.6146 will drive the asset towards the 50-day EMA at 0.6173 and the October 4 high near 0.6220.

NZD/USD daily chart

Economic Indicator

RBNZ Interest Rate Decision

The Reserve Bank of New Zealand (RBNZ) announces its interest rate decision after its seven scheduled annual policy meetings. If the RBNZ is hawkish and sees inflationary pressures rising, it raises the Official Cash Rate (OCR) to bring inflation down. This is positive for the New Zealand Dollar (NZD) since higher interest rates attract more capital inflows. Likewise, if it reaches the view that inflation is too low it lowers the OCR, which tends to weaken NZD.

Read more.

Last release: Wed Oct 09, 2024 01:00

Frequency: Irregular

Actual: 4.75%

Consensus: 4.75%

Previous: 5.25%

Source: Reserve Bank of New Zealand

The Reserve Bank of New Zealand (RBNZ) holds monetary policy meetings seven times a year, announcing their decision on interest rates and the economic assessments that influenced their decision. The central bank offers clues on the economic outlook and future policy path, which are of high relevance for the NZD valuation. Positive economic developments and upbeat outlook could lead the RBNZ to tighten the policy by hiking interest rates, which tends to be NZD bullish. The policy announcements are usually followed by Governor Adrian Orr’s press conference.

 

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Plötzliche Korrektur an den chinesischen Aktienmärkten: Shanghai Composite verliert 4 %, ChiNext fällt um 7 %. Ist die Erholung vorbei?​Insights - Aufgrund höherer Erwartungen an fiskalische Stimulierungsmaßnahmen in China kam es zu einer plötzlichen Korrektur der zuvor stark gestiegenen chinesischen Vermögenswerte, was zu einer abrupten Stimmungswende auf dem Markt führte.
Author  Mitrade
9 hour ago
​Insights - Aufgrund höherer Erwartungen an fiskalische Stimulierungsmaßnahmen in China kam es zu einer plötzlichen Korrektur der zuvor stark gestiegenen chinesischen Vermögenswerte, was zu einer abrupten Stimmungswende auf dem Markt führte.
placeholder
China Stocks Slide on Weaker Economic RecoveryInsights - Chinese assets, which surged recently on hopes for stronger fiscal stimulus, saw a sharp reversal as market sentiment shifted. On Wednesday, mainland Chinese stocks plunged, with major in
Author  Mitrade
9 hour ago
Insights - Chinese assets, which surged recently on hopes for stronger fiscal stimulus, saw a sharp reversal as market sentiment shifted. On Wednesday, mainland Chinese stocks plunged, with major in
placeholder
After downgrading Amazon, Wells Fargo says buy Microsoft stockInvesting.com -- After downgrading Amazon (NASDAQ:AMZN) this week, Wells Fargo (NYSE:WFC) said it is increasing its Microsoft (NASDAQ:MSFT) position, recommending investors focus on the tech giant as part of its "Signature Picks" portfolio.
Author  Investing.com
14 hour ago
Investing.com -- After downgrading Amazon (NASDAQ:AMZN) this week, Wells Fargo (NYSE:WFC) said it is increasing its Microsoft (NASDAQ:MSFT) position, recommending investors focus on the tech giant as part of its "Signature Picks" portfolio.
placeholder
Here’s Why The Dogecoin And Shiba Inu Price Crashed AgainDogecoin and Shiba Inu prices have crashed again following their recent upward trend, which led to significant price gains. These price crashes are primarily due to the current macro environment and market uncertainty, which don’t favor risk assets like these meme coins.
Author  Bitcoinist
14 hour ago
Dogecoin and Shiba Inu prices have crashed again following their recent upward trend, which led to significant price gains. These price crashes are primarily due to the current macro environment and market uncertainty, which don’t favor risk assets like these meme coins.
placeholder
MBX Biosciences earns Buy rating at three investment firmsInvesting.com -- Three major investment firms started research coverage of MBX Biosciences stock on Tuesday, each assigning a Buy rating to the biotechnology company.
Author  Investing.com
14 hour ago
Investing.com -- Three major investment firms started research coverage of MBX Biosciences stock on Tuesday, each assigning a Buy rating to the biotechnology company.
Related Instrument
goTop
quote